Clinical Trials on Cystic Fibrosis, Pulmonary
Total 15094 results
-
Rajan SaggarActelionWithdrawnIdiopathic Pulmonary Fibrosis | Pulmonary Arterial HypertensionUnited States
-
Geno LLCCompletedIdiopathic Pulmonary Fibrosis | Pulmonary Arterial HypertensionUnited States
-
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.Texas Tech University Health Sciences CenterTerminatedPulmonary Disease, Chronic Obstructive | Cough | Pulmonary FibrosisUnited States
-
Wen-Shiou PanCompletedHeart Failure | Stroke | Pulmonary Disease, Chronic Obstructive | Kidney Failure, Chronic | Alzheimer Disease, Late Onset | Kidney Failure, Acute | Cystic Fibrosis Pulmonary Exacerbation | Chronic Liver Disease and CirrhosisTaiwan
-
Cedars-Sinai Medical CenterGenentech, Inc.Recruiting
-
Blade TherapeuticsNot yet recruitingRESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary Fibrosis
-
University Hospital, ToursInstitut National de la Santé Et de la Recherche Médicale, FranceRecruitingIdiopathic Pulmonary FibrosisFrance
-
University of PittsburghJohns Hopkins University; Penn State University; Temple University; University...Active, not recruitingIdiopathic Pulmonary FibrosisUnited States
-
Hoffmann-La RocheTerminatedIdiopathic Pulmonary FibrosisKorea, Republic of, United States, France, Israel, Spain, Belgium, Australia, Czechia, Denmark, Taiwan, Italy, Japan, Singapore, Turkey, Germany, China, New Zealand, Argentina, Portugal, South Africa, Hungary, Canada, Poland, Greece, Ne... and more
-
Novartis PharmaceuticalsTerminatedIdiopathic Pulmonary FibrosisUnited States, Germany, Italy, Canada, Ireland, United Kingdom
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisGreece
-
Assistance Publique - Hôpitaux de ParisCompletedIdiopathic Pulmonary FibrosisFrance
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Netherlands, Italy, Germany, Switzerland, Czechia, Spain
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Belgium, Australia, United Kingdom, Canada, China, Germany, Japan, Turkey, France, Ireland, Italy, Israel, Netherlands, Portugal, Greece, India, Czechia, Chile, Finland, Mexico, Russian Federation
-
Belgian Thoracic SocietyBoehringer Ingelheim; Roche Farma, S.ACompletedIdiopathic Pulmonary FibrosisBelgium, Luxembourg
-
Institut d'Investigació Biomèdica de BellvitgeCompleted
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States
-
University Hospital, ToursCompletedIdiopathic Pulmonary FibrosisFrance
-
Steward St. Elizabeth's Medical Center of Boston...Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States
-
The University of Hong KongQueen Mary Hospital, Hong KongTerminatedIdiopathic Pulmonary FibrosisHong Kong
-
Royal Brompton & Harefield NHS Foundation TrustKings Clinical Trials UnitCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
University of PittsburghNational Institute of Nursing Research (NINR)CompletedIdiopathic Pulmonary FibrosisUnited States
-
Istanbul University-CerrahpasaUnknownIdiopathic Pulmonary FibrosisTurkey
-
Medical College of WisconsinTerminatedIdiopathic Pulmonary FibrosisUnited States
-
Afferent Pharmaceuticals, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Canada, Belgium, Australia, United Kingdom, Germany, Italy, France, Japan, Mexico, India
-
George Papanicolaou HospitalUnknown
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States, Canada, Turkey
-
NYU Langone HealthWithdrawnIdiopathic Pulmonary FibrosisUnited States
-
Genentech, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisUnited States
-
Genentech, Inc.Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimCompletedPulmonary FibrosisUnited States, Canada, Chile, China, Finland, France, Germany, Greece, India, Japan, Korea, Republic of, Mexico, Netherlands, Portugal, Russian Federation, Spain, Turkey
-
The Prince Charles HospitalMater Medical Research InstituteCompletedIdiopathic Pulmonary FibrosisAustralia
-
Centocor, Inc.CompletedPulmonary FibrosisUnited States, Canada, Netherlands, Belgium, Germany
-
University of MichiganNational Institutes of Health (NIH)CompletedIdiopathic Pulmonary FibrosisUnited States
-
University of California, San FranciscoCompleted
-
Gilead SciencesCompletedIdiopathic Pulmonary FibrosisUnited States
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Zambon SpACompletedPulmonary FibrosisSpain, Germany, Belgium, France, Italy, Netherlands, United Kingdom
-
Boehringer IngelheimCompleted
-
Shanghai Pulmonary Hospital, Shanghai, ChinaNanjing Chia-tai Tianqing PharmaceuticalCompletedIdiopathic Pulmonary Fibrosis
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Monash UniversityRecruitingFibrotic Interstitial Lung DiseaseAustralia
-
AmMax Bio, Inc.Withdrawn
-
Novartis PharmaceuticalsTerminatedIdiopathic Pulmonary FibrosisUnited States, United Kingdom
-
FibroGenCompletedIdiopathic Pulmonary FibrosisUnited States, New Zealand, India, South Africa, Australia, Bulgaria, Canada
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI); Brown UniversityCompleted
-
University of Colorado, DenverNational Heart, Lung, and Blood Institute (NHLBI)WithdrawnHealthy | Idiopathic Pulmonary FibrosisUnited States
-
University of MichiganCoalition for Pulmonary FibrosisCompletedIdiopathic Pulmonary FibrosisUnited States